TipRanks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
Want to see DRUG full AI Analyst Report?

Bright Minds Biosciences (DRUG) Technical Analysis

292 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is -5.55, suggesting Bright Minds Biosciences is a Buy.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 60.58, while Bright Minds Biosciences’s (DRUG) share price is $79.49, making it a Sell.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 67.09, while Bright Minds Biosciences’s (DRUG) share price is $79.49, making it a Sell.

Bright Minds Biosciences (DRUG) Pivot Points

Sep 30, 2026, 09:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
46.77
48.16
49.91
51.30
53.05
54.44
56.19
Fibonacci
48.16
49.36
50.10
51.30
52.50
53.24
54.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Sep 30, 2026, 09:09 PM
Period
Simple
Exponential
MA5
52.93Sell
52.83Sell
MA10
56.64Sell
55.95Sell
MA20
61.26Sell
60.58Sell
MA50
70.52Sell
67.09Sell
MA100
71.99Sell
70.69Sell
MA200
77.08Sell
72.78Sell
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 55.95, while Bright Minds Biosciences’s (DRUG) share price is $79.49, making it a Sell.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 70.69, while Bright Minds Biosciences’s (DRUG) share price is $79.49, making it a Sell.
Bright Minds Biosciences’s (DRUG) stock price is $79.49 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 70.52, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is $79.49 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 71.99, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) stock price is $79.49 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 77.08, creating a Sell signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Sep 30, 2026, 09:09 PM
Name
Value
Implied Action
RSI (14)
21.92
Buy
STOCH (9,6)
7.17
Buy
STOCHRSI (14)
5.07
Buy
MACD (12,26)
-5.55
Buy
ADX (14)
41.55
Neutral
Williams %R
-98.74
Buy
CCI (14)
-153.38
Buy
ATR (14)
3.46
-
Ultimate Oscillator
27.76
Sell
ROC
-23.55
Sell
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 21.92, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 41.55, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is -153.38, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is -23.55, creating a Sell signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Sell.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 21.92, which suggests DRUG is a Buy.
      What is DRUG’s MACD?
      DRUG’s MACD is -5.55, which suggests DRUG is a Buy.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 52.93, which suggests DRUG is a Sell.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 61.26, which suggests DRUG is a Sell.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 70.52, which suggests DRUG is a Sell.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 77.08, which suggests DRUG is a Sell.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -98.74, which suggests DRUG is a Buy.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is -153.38, which suggests DRUG is a Buy.